TITLE
Myelodysplastic syndrome: CD34+ hematopoietic stem cells

SUMMARY
Analysis of bone marrow CD34+ hematopoietic stem cells of myelodysplastic syndrome (MDS) patients. MDS is a group of clonal hematopoietic stem cell malignancies characterized by ineffective hematopoiesis. Results provide insight into the molecular pathogenesis of MDS.

ORGANISM
Homo sapiens

